Coronavirus Update - 07th August 2020

We would like to take this opportunity to thank our clients and staff for their continued support over this period of restricted movement. 

We remain open for business as usual and have started welcoming limited numbers of visitors to site

We fully comply with all government guidance on minimising the risks of COVID-19 and have published our risk assessment here

The latest news from Arcinova

April 1, 2020

Arcinova’s Senior Director of Business Development Europe named 2020 Northern Powerhouse Export Champion

Arcinova, a multi-service Contract Development and Manufacturing Organisation (CDMO) based in Northumberland, England, is delighted to announce that its Senior Director of Business Development Eur
March 2, 2020

Fantastic news - we are the highest-placed CDMO on Alantra's #PharmaFast50!

Fantastic news - we are the highest-placed CDMO on Alantra's #PharmaFast50! We are delighted by this recognition of our work as a North East-based CDMO that serves the global Pharma indust
January 31, 2020

Arcinova Releases Latest Case Study - Capsule Product Manufacturing

The challenge - Accelerate first-in-human and Phase II trials for an oral dosage form intended for treatment of CNS disorders. A fully integrated approach was required, to include drug substance m
January 27, 2020

Arcinova Launches Latest Video

Have you ever wondered what our site looks like?  View our video here
January 24, 2020

Arcinova Releases Latest Case Study - Precision Filling

The challenge - To rapidly manufacture a GMP-compliant API-in-capsule product for use in Phase I and Phase II clinical trials.  The product was being investigated for treatments spanning mult
January 24, 2020

2020 Britest Process Understanding Day

This week Rory MacDonald was delighted to attend the 2020 Britest Process Understanding Day to present on how Arcinova has been making use of Britest tools to help capture knowledge and perform te
January 23, 2020

Arcinova Releases Latest Case Study

The challenge - to develop stable sterile formulations of a drug substance for intravenous administration in phase I clinical trials.  The drug substance, intended for the treatment of CNS (C
January 21, 2020

Arcinova Festive Fundraising

This year we filled shoeboxes for the amazing Destiny Streetworx charity, filling 23 boxes in total and sending bags of hand knitted hats and scarves to support the homeless people of the North Ea
January 5, 2020

Arcinova hosts Guinness World Record Holder for STEM Christmas Lecture

We were proud to invite over 150 local schoolchildren to attend a STEM Ambassador Hub North East Christmas Lecture at our facility this month. The event gave pupils from across North Northumberlan




Discover how Arcinova can help

We provide a fully integrated approach to drug development, speak to our team and discover how we can help you fast forward to market.

GET IN TOUCH